”ΕΠΑνΕΚ
Μητροπέτροβα 10, 24 133 Καλαμάτα. Τηλ.: 27210 23501‬, Κιν.: 6945893111
Ώρες λειτουργίας: ΔΕΥ – ΠΕΜ: 08:30 – 17:00, ΠΑΡ – ΚΥΡ: κλειστά
  1. Outer retinal tubulations in maternally inherited diabetes & deafness – associated macular dystrophy: case report.

Syriga M, Soumplis V, Kapernopoulos C, Kleftogiannis D, Karampelas M.
Ophthalmic Genet. 2020 Dec;41(6):606-611.

  1. Phenotypic findings in C1QTNF5 retinopathy (late-onset retinal degeneration; LORD).

Soumplis V, Sergouniotis PI, Robson AG, Michaelides M, Moore AT, Holder GE, Webster AR.
Acta Ophthalmol, 2013 May:91(3):e191-195.

  1. Response of corneal hysteresis and central corneal thickness following clear corneal cataract surgery.

Kandarakis A, Soumplis V, Karampelas M, Koutroumanos I, Panos C, Kandarakis S, Karagiannis D.
Acta Ophthalmol. 2012 Sep; 90(6): 526-9.

  1. Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis).

Karagiannis D, Karampelas M, Soumplis V, Amariotakis C, Georgalas I, Kandarakis A.  
Can J Ophthalmol. 2011 Dec;46(6):486-90.

  1. A case of bilateral self-induced keratoconus in a patient with Tourette syndrome associated with compulsive eye rubbing: case report.

Kandarakis A, Karampelas M, Soumplis V, Panos C, Makris N, Kandarakis S, Karagiannis D.
BMC Ophthalmol. 2011 Sep 21;11(1):28.

  1. Comparison of Dynamic Contour Tonometry and Goldmann Applanation Tonometry following Penetrating Keratoplasty.

Kandarakis A, Soumplis V, Pitsas C, Kandarakis S, Halikias J, Karagiannis D.
Can J Ophthalmol. 2010 Oct;45(5):489-93.

  1. Efficacy of brimonidine in preventing intraocular pressure spikes following phacoemulsification in glaucoma patients.

Kandarakis A, Soumplis V, Karampelas M, Panos C, Kyriakos N, Baxevanakis A, Karagiannis D.
Eur J Ophthalmol. 2010 Nov-Dec;20(6):994-9.

  1. Ranibizumab for idiopathic retinal vasculitis, aneurysms, and neuroretinitis: favorable results.

Karagiannis D, Soumplis V, Georgalas I, Kandarakis A.
Eur J Ophthalmol. 2010 Jul-Aug;20(4):792-4.

  1. Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Karagiannis D, Ladas I, Parikakis E, Georgalas I, Kotsolis A, Amariotakis G, Soumplis V, Mitropoulos P.
Clinical Interventions in Aging 2009;4:457–461.

  1. A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients.

Karagiannis D, Soumplis V, Kandarakis A.
Clinical Interventions in Aging 2009;4:315–317.

  1. An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum.

Karampelas M, Soumplis V, Webster A.
Greek Annals of Ophthalmology 2011;4:404-406.

  1. Optimization of constants of intraocular lenses after cataract surgery.

Soumplis V, Karampelas M, Panos C, Giannopoulou PK, Arxontides I, Kafetsouli D, Dipla A, Makris N, Kandarakis A.
Greek Annals of Ophthalmology 2010;3:257-261.

  1. Intravitreal injection of ranibizumab for the treatment of choroidal neovascularization in age-related macular degeneration.

Karagiannis D, Labrinakis I, Konstantinidou V, Soumplis V, Kiriakos N, Panos C, Kafetsouli D, Kandarakis A.
Greek Annals of Ophthalmology 2009;1:22-7.

  1. Penetrating and non-penetrating glaucoma surgery.

Kandarakis A, Koutroumanos I, Soumplis V, Panos C, Giannopoulou PK, Arxontides I, Psichogiou E.
Greek Ophthalmic Congress Year Book 2009, 85-90.

  1. Management of cataract and glaucoma.

Kandarakis A, Koutroumanos I, Soumplis V, Panos C, Giannopoulou PK, Dipla A, Kafetsouli D.
Greek Ophthalmic Congress Year Book 2009, 115-122.

  1. Measuring intraocular pressure – new technologies.

Kandarakis A, Pitsas C, Soumplis V.
Greek Ophthalmic Congress Year Book 2007, 93-98.

el
Μετάβαση στο περιεχόμενο